Maravai Lifesciences Holdings, Inc.: KeyBanc raises to overweight from sector weight
MRVI•KeyBanc raised its rating on Maravai Lifesciences Holdings to overweight from sector weight.
Related News
AIRO Q3 net loss widens 51% to $12 million; Q3 revenue more than doubles to $17.51 million
AIRO•
Data I/O Corporation Q3 EPS USD -0.27
DAIO•
VinFast delivers 22,896 EVs in Vietnam in October
VFS•
Only 15% of enterprises fully tie AI investment to P&L outcomes, Genpact finds
G•
FTSE 100 rises on strong earnings; healthcare, industrials lead
EWU•